BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 26145249)

  • 41. Host-Based Peripheral Blood Gene Expression Analysis for Diagnosis of Infectious Diseases.
    Holcomb ZE; Tsalik EL; Woods CW; McClain MT
    J Clin Microbiol; 2017 Feb; 55(2):360-368. PubMed ID: 27795332
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exosomes: From Functions in Host-Pathogen Interactions and Immunity to Diagnostic and Therapeutic Opportunities.
    Carrière J; Barnich N; Nguyen HT
    Rev Physiol Biochem Pharmacol; 2016; 172():39-75. PubMed ID: 27600934
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Omics-based biomarkers: current status and potential use in the clinic.
    Quezada H; Guzmán-Ortiz AL; Díaz-Sánchez H; Valle-Rios R; Aguirre-Hernández J
    Bol Med Hosp Infant Mex; 2017; 74(3):219-226. PubMed ID: 29382490
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genomics, transcriptomics and proteomics to elucidate the pathogenesis of rheumatoid arthritis.
    Song X; Lin Q
    Rheumatol Int; 2017 Aug; 37(8):1257-1265. PubMed ID: 28493174
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Complications of sepsis: the role of risk prediction rules, biomarkers and host genetics.
    Haeusler GM; Slavin MA
    Expert Rev Anti Infect Ther; 2012 Jul; 10(7):733-5. PubMed ID: 22943396
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proteomics Tracing the Footsteps of Infectious Disease.
    Greco TM; Cristea IM
    Mol Cell Proteomics; 2017 Apr; 16(4 suppl 1):S5-S14. PubMed ID: 28163258
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sepsis biomarkers: an omics perspective.
    Liu X; Ren H; Peng D
    Front Med; 2014 Mar; 8(1):58-67. PubMed ID: 24481820
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Emerging aspects of molecular biomarkers for diagnosis, prognosis and treatment response in rheumatoid arthritis.
    Márquez A; Martín J; Carmona FD
    Expert Rev Mol Diagn; 2016 Jun; 16(6):663-75. PubMed ID: 27043155
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lipidomics applications for disease biomarker discovery in mammal models.
    Zhao YY; Cheng XL; Lin RC; Wei F
    Biomark Med; 2015; 9(2):153-68. PubMed ID: 25689902
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Application of metabolomics in research of plant metabolites].
    Dan M; Gao XF; Xie GX; Liu Z; Zhao AH; Jia W
    Zhongguo Zhong Yao Za Zhi; 2007 Nov; 32(22):2337-41. PubMed ID: 18257252
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biomarkers in cardiovascular diseases: how can the "-omics" revolution be applicable at the bedside. Introduction.
    Tang WH
    Prog Cardiovasc Dis; 2012; 55(1):1-2. PubMed ID: 22824104
    [No Abstract]   [Full Text] [Related]  

  • 52. The role of genomics to identify biomarkers and signaling molecules during severe sepsis.
    Douglas JJ; Roussel JA
    Minerva Anestesiol; 2016 Mar; 82(3):343-58. PubMed ID: 26091010
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Infectious diseases--new horizons].
    Spirer Z; Barzilai A
    Harefuah; 2012 Aug; 151(8):483-7, 496. PubMed ID: 23350296
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 'Omics' techniques for identifying flooding-response mechanisms in soybean.
    Komatsu S; Shirasaka N; Sakata K
    J Proteomics; 2013 Nov; 93():169-78. PubMed ID: 23313220
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Emerging technologies in point-of-care molecular diagnostics for resource-limited settings.
    Peeling RW; McNerney R
    Expert Rev Mol Diagn; 2014 Jun; 14(5):525-34. PubMed ID: 24784765
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Syrian Hamster as an Animal Model for the Study on Infectious Diseases.
    Miao J; Chard LS; Wang Z; Wang Y
    Front Immunol; 2019; 10():2329. PubMed ID: 31632404
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolomics and Personalized Medicine.
    Koen N; Du Preez I; Loots du T
    Adv Protein Chem Struct Biol; 2016; 102():53-78. PubMed ID: 26827602
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical microbiology in detection and identification of emerging microbial pathogens: past, present and future.
    Wang H; Zhang W; Tang YW
    Emerg Microbes Infect; 2022 Dec; 11(1):2579-2589. PubMed ID: 36121351
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Linking Biomarker and Comparative Omics to Pathogens in Legumes.
    Diapari M
    Curr Issues Mol Biol; 2016; 19():137-44. PubMed ID: 26364313
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Discovery and development of biomarkers of neurological disease.
    Dunckley T; Coon KD; Stephan DA
    Drug Discov Today; 2005 Mar; 10(5):326-34. PubMed ID: 15749281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.